Bradford B. Walters
Vice President and Chief Medical Officer
Brad Walters, MD, PhD, MBA, is a vice president and the chief medical officer of RTI International. After completing his PhD, MD, a surgical internship, and a neurosurgical residency, he joined the faculty of the University of North Carolina at Chapel Hill School of Medicine, where he assisted in establishing the radiosurgery program and the epilepsy surgery program. His research focused on central nervous system trauma. After completing his MBA, he joined Academy Funds serving as principal and then partner, and on the boards of directors of Kucera Pharmaceutical Company, ParinGenix, and Curry Pharmaceuticals. He was then appointed a member of the Building Entrepreneurial Companies Work Group of the North Carolina Biotechnology Center Strategic Plan, and to the Governor's Task Force on Nanotechnology and North Carolina's Economy. From 1999 through 2006, he served as a member of the board of directors of NCHICA. Dr. Walters has brought three new chemical entities into five Phase I clinical trials.
PhD, Anatomy and Embryology, University of London; MD (cum laude), Harvard Medical School/Massachusetts Institute of Technology Division of Health Sciences and Technology; MBA, Kenan-Flagler Business School, University of North Carolina at Chapel Hill; AB, Chemistry and Physics (summa cum laude), Harvard College.
- Preclinical and Clinical Development
- Neurological Surgery
- May 22, 2014
New drug safety book brings together 136 experts from around the world
– News Release